20160302 March April 2016 IR events ENG
Year: 2016
Transgene and ABL Announce the Acquisition by ABL Europe of Transgene’s Production Asset
20160203 PR ABL TG SYMPHONY
EIB lends EUR 20m to Transgene
20160128 PR transgene BEI final version
Transgene Announces Financial Calendar for 2016
20160108 financial calendar_EN ver 1
Transgene enters new phase in its strategic development
20160107 Strategic update ENG clean
Transgene Announces First Patient Randomized in Multinational Phase 3 Trial for Pexa-Vec Oncolytic Immunotherapy in Advanced Liver Cancer
20160106 Ph 3 pexa vec in HCC trial initiation VER8
